Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
They get their confidence, femininity and individuality back
Clinical trials extending 68 weeks show acceptable safety profiles with no unexpected serious adverse events
Clinically meaningful responses in insulin-resistant patients typically include a reduction in fasting insulin of 20-40% and an improvement in HOMA-IR within 8-12 weeks at therapeutic doses, though individual variability is wide [1]
After exploring options with a functional medicine provider, Alex began a short cycle of 5-Amino-1MQ, paired with moderate resistance training and a high-protein diet
US$ 21.58
US$ 23.46
US$ 21.80
US$ 29.44
